Correction

Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System

N Engl J Med 2010; 362:1056March 18, 2010

Article

Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System (Original Article, N Engl J Med 2008:358;2457 - 2467) and Outbreak of Adverse Reactions Associated with Contaminated Heparin (Original Article, N Engl J Med 2008:359;2674 - 2684) . The disclosure statements should have included the following: “Dr. Sasisekharan reports being a named inventor on issued and pending patents concerning the structure and biology of complex glycosaminoglycans.” We regret the errors.